ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative) - USD ($)																					1 Months Ended	3 Months Ended				9 Months Ended		12 Months Ended
		Oct. 16, 2024	Oct. 05, 2024	Sep. 26, 2024	Aug. 26, 2024	Jul. 24, 2024	Jul. 09, 2024	Jun. 28, 2024	May 24, 2024	May 24, 2024	May 22, 2024	May 21, 2024	May 17, 2024	Apr. 26, 2024	Apr. 24, 2024	Apr. 08, 2024	Apr. 05, 2024	Jan. 18, 2024	Dec. 19, 2023	Dec. 15, 2023	Mar. 31, 2023	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Apr. 04, 2024	Jan. 22, 2024	Mar. 20, 2023
Proceeds from sale of common stock																										$ 568,270	$ 5,000,000
Stockholders equity reverse stock split		1-for-15 reverse stock split	the Company announced that the Board of Directors approved a reverse stock split of its common stock at a ratio of 1-to-15 (“Reverse Stock Split”). The Reverse Stock Split was completed on October 16, 2024 and resulted in 39,019,354 issued and outstanding shares of common stock being reduced to 2,134,625 shares of common stock.																							1 for 15 reverse stock split		1 for 15 reverse stock split
Exercise price								$ 2.53
Number of shares issued, value																						$ 388,270	$ 180,000	$ 1,024,500	$ 5,000,000
MangoRx Mexico [Member]
Equity ownership percentage																										98.00%
MangoRx UK Limited [Member]
Equity ownership percentage																										100.00%
Series B Preferred Stock [Member]
Number of shares issued				140		50	135		128,243	150	155	50
Purchase price				$ 3.21		$ 4.90	$ 4.15		$ 3.045	$ 3.045
Number of shares sold				250	500	50	135	1,000
Sale of stock value				$ 250,000	$ 500,000
Number of shares issued, value				$ 154,000		$ 11,000	$ 148,500		$ 390,500	$ 165,000	$ 170,500	$ 55,000
Series B Preferred Stock [Member] | Thrid Closing Date [Member]
Number of shares sold								750
Common Stock [Member]
Number of shares issued	[1]																					63,333	40,000	68,300	83,333
Number of shares sold																			266,667
Issuance of shares																			$ 1,200,000
Sale of stock value																			$ 1,000,000.0
Number of shares issued, value																						$ 6	$ 4	$ 7	$ 8
Share price																			$ 4.50
Warrant [Member]
Number of shares issued, value
Warrant One [Member] | Thrid Closing Date [Member]
Number of warrants to purchase of common stock								66,667
Exercise price								$ 7.50
Warrant Two [Member] | Thrid Closing Date [Member]
Number of warrants to purchase of common stock								33,333
Exercise price								$ 15.00
Underwriting Agreement [Member] | Warrant [Member]
Number of warrants to purchase of common stock																			18,667											2,800
Exercise price																			$ 5.70											$ 5.63
Underwriting Agreement [Member] | Boustead Securities LLC [Member]
Number of shares issued																				266,667
Purchase price																				$ 4.50
Securities Purchase Agreement [Member] | Series B Preferred Stock [Member]
Number of shares issued																	1,500
Number of shares sold													100	150			500
Sale of stock value													$ 100,000	$ 150,000
Number of shares issued, value																	$ 1,650,000
Securities Purchase Agreement [Member] | Warrant [Member]
Exercise price								7.50																					$ 3.90
Warrants to purchase common stock																	220,000												220,000
Purchase price of warrants																	$ 1,500,000
Aggregate amount for warrant																	$ 500,000
Securities Purchase Agreement [Member] | Warrant One [Member]
Exercise price								$ 15.00
Equity Purchase Agreement [Member]
Number of shares issued											46,667	16,667				66,667	66,667
Purchase price											$ 7.20	$ 7.20
Number of shares issued, value											$ 337,915	$ 119,750				$ 25,000,000	$ 214,900
Share price																	$ 3.22
Equity Purchase Agreement [Member] | Maximum [Member]
Number of shares issued, value																	$ 25,000,000
IP Purchase Agreement [Member] | Series C Preferred Stock [Member]
Number of shares issued															980,000
Sale of stock value																										$ 25,000
Number of shares issued, value															$ 19,600,000
Share price															$ 20.00
Consideration amount															$ 20,000,000
Cash															$ 400,000
Cumulative preferred stock description															(i) with $200,000 payable on or before June 30, 2024, (ii) $100,000 payable on or before August 31, 2024, and (iii) $100,000 payable on or before November 30, 2024.
IPO [Member]
Number of shares issued																					83,333
Purchase price																					$ 60.00				$ 60.00
Proceeds from sale of common stock																					$ 4,350,000
IPO [Member] | Common Stock [Member]
Number of warrants to purchase of common stock																			18,667												5,833
Exercise price																			$ 5.70												$ 75.00
Resale Prospectus [Member]
Number of shares issued																					133,333
Purchase price																					$ 15.00				$ 15.00
Number of shares sold																					317,667
Over-Allotment Option [Member] | Underwriters [Member]
Number of shares issued																		40,000
Proceeds from sale of common stock																		$ 160,000
Number of shares sold																		306,667
Over-Allotment Option [Member] | Underwriting Agreement [Member] | Boustead Securities LLC [Member]
Number of shares issued																				40,000

[1] Shares have been retroactively adjusted to reflect the decreased number of shares resulting from a 1 for 15 reverse stock split